Fri, Aug 22, 2014, 8:52 AM EDT - U.S. Markets open in 38 mins.


% | $
Quotes you view appear here for quick access.

Cenveo Inc. Message Board

Brian 3 posts  |  Last Activity: Aug 13, 2014 12:44 AM Member since: Dec 15, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Brian Brian Aug 13, 2014 12:44 AM Flag

    Here's a news flash for you. The same people providing peer reviews for reputable journals are also providing written reviews and serving on panels for the FDA. The study you're misrepresenting was actually a cool little experiment meant to shine some light on the increasing number of 'pay-to-publish' lower tier open access journals (not journals INO publishes in).

    "To test these reviewers, Bohannon submitted versions of his study to 304 open-access journals over the course of the year. The name of the cancer, lichen, and drug in each version was essentially picked out of a hat, along with an equally random, made-up name and institution for an author situated in an African capital.

    Only 255 journals responded.

    The journals tested were ones with relevant medical or biological titles for a cancer study, such as the European Journal of Chemistry or the International Journal of Cancer and Tumor (the latter edited by a "Grace Groovy," according to correspondence with Bohannon). Most appear to be headquartered in India and the United States..."

    This should be enough for people to find the rest if they want the whole story...

  • The short interest has jumped and that is normally a bad thing for this stock. I'm going to be really #$%$ if this stock tanks after earnings because as usual somebody knows something that we don't.

  • The shorts feel the need to do it right now. I wonder why;^)

3.17+0.10(+3.26%)Aug 21 4:03 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.